Nyxoah sees Q2 revenue up 73%, plans R&D shift to U.S. and Belgium; shares rise

2 hours ago 1
Apprentice engineer in medical electronics machinery manufacturing factory

Monty Rakusen

  • Nyxoah SA (NASDAQ:NYXH) Monday said that Q2 revenue is anticipated to be about €1.3 million, a 73% increase from a year ago, and expects to transition all ongoing R&D activities from Israel to the U.S. and Belgium.
  • Cash, cash equivalents, and financial

Recommended For You

More Trending News

Read Entire Article